| Engineering a versatile and retrievable cell macroencapsulation device for the delivery of therapeutic proteins | iScience |  | | 2023 | 105 | 71 |
|
| Sustained delivery of low-dose anti-CTLA-4 by genetically engineered encapsulated cells to the tumor microenvironment drives tumor response and prolongs survival in a colorectal cancer model | AACR Annual Meeting 2023 | | | 2023 | 81 | 199 |
|
| Immortalised human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology | Molecular therapy. Methods & clinical development | | | 2022 | 251 | 182 |
|
